Low-dose iron chelation as anti-oxidative therapy in patients with sickle cell disease: A single-centre pilot study

Aafke E. Gaartman; Boukje M. Beuger; Lydian A. de Ligt; Martijn Veldthuis; Hanke L. Matlung; Joost C.M. Meijers; Casper G. Schalkwijk; Koen de Heer; Jarom Heijmans; Rob van Zwieten; Bart J. Biemond; Robin van Bruggen; Erfan Nur

doi:10.1111/bjh.19943

Low-dose iron chelation as anti-oxidative therapy in patients with sickle cell disease: A single-centre pilot study

Aafke E. Gaartman^*
, Boukje M. Beuger
, Lydian A. de Ligt
, Martijn Veldthuis
, Hanke L. Matlung
, Joost C.M. Meijers
, Casper G. Schalkwijk
, Koen de Heer
, Jarom Heijmans
, Rob van Zwieten
, Bart J. Biemond
, Robin van Bruggen
, Erfan Nur

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1010-1013
Number of pages	4
Journal	British Journal of Haematology
Volume	206
Issue number	3
Early online date	1 Jan 2024
DOIs	https://doi.org/10.1111/bjh.19943
Publication status	Published - Mar 2025

Access to Document

10.1111/bjh.19943

Cite this

Gaartman, A. E., Beuger, B. M., de Ligt, L. A., Veldthuis, M., Matlung, H. L., Meijers, J. C. M., Schalkwijk, C. G., de Heer, K., Heijmans, J., van Zwieten, R., Biemond, B. J., van Bruggen, R., & Nur, E. (2025). Low-dose iron chelation as anti-oxidative therapy in patients with sickle cell disease: A single-centre pilot study. British Journal of Haematology, 206(3), 1010-1013. https://doi.org/10.1111/bjh.19943

@article{20081a3e79ab41b8a7e333f7b741b47f,

title = "Low-dose iron chelation as anti-oxidative therapy in patients with sickle cell disease: A single-centre pilot study",

author = "Gaartman, \{Aafke E.\} and Beuger, \{Boukje M.\} and \{de Ligt\}, \{Lydian A.\} and Martijn Veldthuis and Matlung, \{Hanke L.\} and Meijers, \{Joost C.M.\} and Schalkwijk, \{Casper G.\} and \{de Heer\}, Koen and Jarom Heijmans and \{van Zwieten\}, Rob and Biemond, \{Bart J.\} and \{van Bruggen\}, Robin and Erfan Nur",

note = "Funding Information: This study was supported by a grant from the Stichting Amsterdam UMC Foundation.",

year = "2025",

month = mar,

doi = "10.1111/bjh.19943",

language = "English",

volume = "206",

pages = "1010--1013",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley \& Sons Inc.",

number = "3",

}

Gaartman, AE, Beuger, BM, de Ligt, LA, Veldthuis, M, Matlung, HL, Meijers, JCM, Schalkwijk, CG, de Heer, K, Heijmans, J, van Zwieten, R, Biemond, BJ, van Bruggen, R & Nur, E 2025, 'Low-dose iron chelation as anti-oxidative therapy in patients with sickle cell disease: A single-centre pilot study', British Journal of Haematology, vol. 206, no. 3, pp. 1010-1013. https://doi.org/10.1111/bjh.19943

TY - JOUR

T1 - Low-dose iron chelation as anti-oxidative therapy in patients with sickle cell disease

T2 - A single-centre pilot study

AU - Gaartman, Aafke E.

AU - Beuger, Boukje M.

AU - de Ligt, Lydian A.

AU - Veldthuis, Martijn

AU - Matlung, Hanke L.

AU - Meijers, Joost C.M.

AU - Schalkwijk, Casper G.

AU - de Heer, Koen

AU - Heijmans, Jarom

AU - van Zwieten, Rob

AU - Biemond, Bart J.

AU - van Bruggen, Robin

AU - Nur, Erfan

N1 - Funding Information: This study was supported by a grant from the Stichting Amsterdam UMC Foundation.

PY - 2025/3

Y1 - 2025/3

U2 - 10.1111/bjh.19943

DO - 10.1111/bjh.19943

M3 - Comment/Letter to the editor

SN - 0007-1048

VL - 206

SP - 1010

EP - 1013

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 3

ER -